Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Discover the highest cash back credit card for all purchases and learn how to maximize your rewards effectively.
24,876 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Garmin delivered a dominant Q4 with a big EPS beat and revenue surge, triggering a sharp market rally as investors we...
A single message from Elon Musk can ripple through the stock market, nudging indices like Nasdaq and the S&P 500. Thi...
A new humanoid robot from a major player has people talking. This article breaks down what a rival with a familiar lo...
When oil surges, mining companies feel the sting long before metals move. This article breaks down how energy costs p...
When insiders move stock, investors pay attention. This article breaks down what iradimed’s founder sold 7,500 means ...
The prospect of SpaceX going public has investors buzzing. History shows mega IPOs behave in patterns that can surpri...
Block announces a sweeping AI-driven overhaul, cutting staff by more than 4,000 and reorganizing around a leaner oper...
If you want to grow wealth over the long term, you need to pick investments with staying power. Here are three S&P 50...
Marvell Technology has surged in 2026 as AI infrastructure demand accelerates. Here is a timely look at the case for ...
A single headline can move stock in moments, but the real story is rarely a simple one. This article dives into why a...
Tesla sits around $445 as Q1 margin gains meet AI roadmap momentum, prompting fresh Buy, Sell or Hold questions for i...